Selective or nonselective endothelin antagonists in porcine hypoxic pulmonary hypertension?

被引:20
作者
Franco-Cereceda, A [1 ]
Holm, P [1 ]
机构
[1] Karolinska Hosp, Dept Thorac Surg, S-17176 Stockholm, Sweden
关键词
endothelin; hypoxia; pig; pulmonary circulation;
D O I
10.1097/00005344-199800001-00128
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We evaluated the hemodynamic effects of various endothelin (ET) receptor antagonists using selective and nonselective ETA and ETB receptor blockade in hypoxic pigs in vivo. BMS-182874 (10 mg/kg i.v.) TBC-1125lz (10 mg/kg i.v.), selective ETA receptor antagonists, attenuated hypoxia (Fi02 0.1)-evoked increase in pulmonary arterial pressure and pulmonary vascular resistance. Bosentan (10 mg/kg Lv.) a nonselective ETA and ETB receptor antagonist, cause essentially similar effects as ETA antagonism alone. No effects were observed after selective ETB blockade using BQ-788 (total dose 1 mg i.v.). The vasoconstrictor effect of exogenous ET was most effectively antagonized by TBC-11251z, followed by BMS-182874 and bosentan. The pulmonary vasodilator effect exerted by exogenous ET during hypoxia was reversed by BQ-788 and bosentan but not by TBC-11251z or BMS-182874. We can therefore conclude that ET contributes to hypoxic pulmonary vasoconstriction primarily through ETA receptor activation.
引用
收藏
页码:S447 / S452
页数:6
相关论文
共 50 条
  • [41] Lung Mast Cells and Hypoxic Pulmonary Hypertension
    Maxova, H.
    Herget, J.
    Vizek, M.
    PHYSIOLOGICAL RESEARCH, 2012, 61 (01) : 1 - 11
  • [42] Change in pharmacological effect of endothelin receptor antagonists in rats with pulmonary hypertension: Role of ETB-receptor expression levels
    Sauvageau, Stephanie
    Thorin, Eric
    Villeneuve, Louis
    Dupuis, Jocelyn
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2009, 22 (04) : 311 - 317
  • [43] The ETA receptor antagonist, BMS-182874, reduces acute hypoxic pulmonary hypertension in pigs in vivo
    Holm, P
    Liska, J
    Franco-Cereceda, A
    CARDIOVASCULAR RESEARCH, 1998, 37 (03) : 765 - 771
  • [44] Dual ETA/ETB vs. selective ETA endothelin receptor antagonism in patients with pulmonary hypertension
    Opitz, C. F.
    Ewert, R.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2006, 36 : 1 - 9
  • [45] Endothelin, but not angiotensin II, contributes to the hypoxic contractile response of large isolated pulmonary arteries in the rat
    Pape, D
    Goineau, S
    Guillo, P
    Durand-Castel, X
    Bellissant, E
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1999, 13 (04) : 461 - 467
  • [46] Can intravenous endothelin-1 be used to enhance hypoxic pulmonary vasoconstriction in healthy humans?
    Talbot, N. P.
    Balanos, G. M.
    Robbins, P. A.
    Dorrington, K. L.
    BRITISH JOURNAL OF ANAESTHESIA, 2008, 101 (04) : 466 - 472
  • [47] Recent developments in the management of resistant hypertension: focus on endothelin receptor antagonists
    Nejad, Sayeh Heidari
    Azzam, Omar
    Schlaich, Markus P.
    FUTURE CARDIOLOGY, 2024, 20 (09) : 435 - 445
  • [48] Contribution of endothelin to pulmonary vascular tone under normoxic and hypoxic conditions
    Johnson, W
    Nohria, A
    Garrett, L
    Fang, JC
    Igo, J
    Katai, M
    Ganz, P
    Creager, MA
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2002, 283 (02): : H568 - H575
  • [49] Increased pulmonary prostacyclin synthesis in rats with chronic hypoxic pulmonary hypertension
    Blumberg, FC
    Lorenz, C
    Wolf, K
    Sandner, P
    Riegger, GAJ
    Pfeifer, M
    CARDIOVASCULAR RESEARCH, 2002, 55 (01) : 171 - 177
  • [50] Prolonged endothelin a receptor blockade attenuates chronic pulmonary hypertension in the ovine fetus
    Ivy, DD
    Parker, TA
    Ziegler, JW
    Galan, HL
    Kinsella, JP
    Tuder, RN
    Abman, SH
    JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (06) : 1179 - 1186